GlucoTrack, Inc. (NASDAQ:GCTK) Sees Significant Increase in Short Interest

GlucoTrack, Inc. (NASDAQ:GCTK) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 394,100 shares, a growth of 359.9% from the November 30th total of 85,700 shares. Currently, 4.4% of the company’s shares are short sold. Based on an average trading volume of 474,700 shares, the short-interest ratio is presently 0.8 days.

GlucoTrack Trading Down 0.8 %

Shares of GCTK traded down $0.00 during midday trading on Friday, hitting $0.26. The stock had a trading volume of 161,334 shares, compared to its average volume of 145,164. GlucoTrack has a 1 year low of $0.20 and a 1 year high of $4.95. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.14 and a quick ratio of 0.14. The stock’s 50 day moving average is $0.78 and its 200 day moving average is $1.64. The firm has a market cap of $4.21 million, a PE ratio of -0.09 and a beta of -0.17.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.